Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase

被引:15
作者
Dick, Samual D. [1 ,4 ]
Federico, Stefania [2 ]
Hughes, Siobhan M. [1 ]
Pye, Valerie E. [1 ]
O'Reilly, Nicola [2 ]
Cherepanov, Peter [1 ,3 ]
机构
[1] Francis Crick Inst, Chromatin Struct & Mobile DNA, London NW1 1AT, England
[2] Francis Crick Inst, Peptide Synth Lab, London NW1 1AT, England
[3] Imperial Coll London, Div Med, London W2 1PG, England
[4] British Heart Fdn, Greater London House,180 Hampstead Rd, London NW1 7AW, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
DNA-DAMAGE CHECKPOINT; PROTEIN-KINASE; S-PHASE; BISUBSTRATE INHIBITORS; PHOSPHORYLATION SITES; MOLECULAR-MECHANISM; CDC7-DBF4; REPLICATION; BINDING; INITIATION;
D O I
10.1016/j.str.2020.05.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CDC7 is an essential Ser/Thr kinase that acts upon the replicative helicase throughout the S phase of the cell cycle and is activated by DBF4, Here, we present crystal structures of a highly active human CDC7-DBF4 construct. The structures reveal a zinc-finger domain at the end of the kinase insert 2 that pins the CDC7 activation loop to motif M of DBF4 and the C lobe of CDC7. These interactions lead to ordering of the substrate-binding platform and full opening of the kinase active site. In a co-crystal structure with a mimic of MCM2 Ser40 phosphorylation target, the invariant CDC7 residues Arg373 and Arg380 engage phospho-Ser41 at substrate P+1 position, explaining the selectivity of the S-phase kinase for Ser/Thr residues followed by a pre-phosphorylated or an acidic residue. Our results clarify the role of DBF4 in activation of CDC7 and elucidate the structural basis for recognition of its preferred substrates.
引用
收藏
页码:954 / +
页数:13
相关论文
共 87 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]   Briefly Bound to Activate: Transient Binding of a Second Catalytic Magnesium Activates the Structure and Dynamics of CDK2 Kinase for Catalysis [J].
Bao, Zhao Qin ;
Jacobsen, Douglas M. ;
Young, Matthew A. .
STRUCTURE, 2011, 19 (05) :675-690
[3]   Structural basis of Aurora-A activation by TPX2 at the mitotic spindle [J].
Bayliss, R ;
Sardon, T ;
Vernos, I ;
Conti, E .
MOLECULAR CELL, 2003, 12 (04) :851-862
[4]   Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation [J].
Bonte, Dorine ;
Lindvall, Charlotta ;
Liu, Honyu ;
Dykema, Karl ;
Furge, Kyle ;
Weinreich, Michael .
NEOPLASIA, 2008, 10 (09) :920-U31
[5]   The Role of Dbf4-Dependent Protein Kinase in DNA Polymerase ζ-Dependent Mutagenesis in Saccharomyces cerevisiae [J].
Brandao, Luis N. ;
Ferguson, Rebecca ;
Santoro, Irma ;
Jinks-Robertson, Sue ;
Sclafani, Robert A. .
GENETICS, 2014, 197 (04) :1111-1122
[6]   CDC7 PROTEIN-KINASE ACTIVITY IS REQUIRED FOR MITOSIS AND MEIOSIS IN SACCHAROMYCES-CEREVISIAE [J].
BUCK, V ;
WHITE, A ;
ROSAMOND, J .
MOLECULAR & GENERAL GENETICS, 1991, 227 (03) :452-457
[7]   Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma [J].
Cao, Ji-Xiang ;
Lu, Yao .
ONCOTARGETS AND THERAPY, 2019, 12 :63-74
[8]   Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells [J].
Charych, Deborah H. ;
Coyne, Mazie ;
Yabannavar, Asha ;
Narberes, Jamie ;
Chow, Sylvia ;
Wallroth, Marco ;
Shafer, Cynthia ;
Walter, Annette O. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (03) :1075-1086
[9]   Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach [J].
Cheng, An Ning ;
Lo, Yu-Kang ;
Lin, Yi-Sheng ;
Tang, Tswen-Kei ;
Hsu, Chun-Hua ;
Hsu, John T-A ;
Lee, Alan Yueh-Luen .
EBIOMEDICINE, 2018, 36 :241-251
[10]   Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents [J].
Cheng, An Ning ;
Jiang, Shih Sheng ;
Fan, Chi-Chen ;
Lo, Yu-Kang ;
Kuo, Chan-Yen ;
Chen, Chung-Hsing ;
Liu, Ying-Lan ;
Lee, Chun-Chung ;
Chen, Wei-Shone ;
Huang, Tze-Sing ;
Wang, Tao-Yeuan ;
Lee, Alan Yueh-Luen .
CANCER LETTERS, 2013, 337 (02) :218-225